Interestingly, unlike some previous studies that have suggested elevated serum sHLA-G levels are correlated with poor prognosis and immune suppression [29, 30], we did not find a significant association between sHLA-G levels and clinicopathological factors in CRC patients. Here, HLA-G is linked to colorectal carcinoma.